Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Armodafinil Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 50 mg Tablets
  • 1.4.3 150 mg Tablets
  • 1.4.4 200 mg Tablets
  • 1.4.5 250 mg Tablets
• 1.5 Market by Application
  • 1.5.1 Global Armodafinil Market Share by Application (2014-2025)
  • 1.5.2 Obstructive Sleep Apnea (OSA) and Narcolepsy
  • 1.5.3 Shift Work Disorder (SWD)
  • 1.5.4 Patients with Severe Hepatic Impairment
  • 1.5.5 Geriatric Patients
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Armodafinil Market Size
• 2.2 Armodafinil Growth Trends by Regions
  • 2.2.1 Armodafinil Market Size by Regions (2014-2025)
  • 2.2.2 Armodafinil Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Armodafinil Market Size by Manufacturers
  • 3.1.1 Global Armodafinil Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Armodafinil Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Armodafinil Market Concentration Ratio (CR5 and HHI)
• 3.2 Armodafinil Key Players Head office and Area Served
• 3.3 Key Players Armodafinil Product/Solution/Service
• 3.4 Date of Enter into Armodafinil Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Armodafinil Market Size by Type (2014-2019)
• 4.2 Global Armodafinil Market Size by Application (2014-2019)

5 United States

• 5.1 United States Armodafinil Market Size (2014-2019)
• 5.2 Armodafinil Key Players in United States
• 5.3 United States Armodafinil Market Size by Type
• 5.4 United States Armodafinil Market Size by Application

6 Europe

• 6.1 Europe Armodafinil Market Size (2014-2019)
• 6.2 Armodafinil Key Players in Europe
• 6.3 Europe Armodafinil Market Size by Type
• 6.4 Europe Armodafinil Market Size by Application

7 China

• 7.1 China Armodafinil Market Size (2014-2019)
• 7.2 Armodafinil Key Players in China
• 7.3 China Armodafinil Market Size by Type
• 7.4 China Armodafinil Market Size by Application

8 Japan

• 8.1 Japan Armodafinil Market Size (2014-2019)
• 8.2 Armodafinil Key Players in Japan
• 8.3 Japan Armodafinil Market Size by Type
• 8.4 Japan Armodafinil Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Armodafinil Market Size (2014-2019)
• 9.2 Armodafinil Key Players in Southeast Asia
• 9.3 Southeast Asia Armodafinil Market Size by Type
• 9.4 Southeast Asia Armodafinil Market Size by Application

10 India

• 10.1 India Armodafinil Market Size (2014-2019)
• 10.2 Armodafinil Key Players in India
• 10.3 India Armodafinil Market Size by Type
• 10.4 India Armodafinil Market Size by Application

11 Central & South America

• 11.1 Central & South America Armodafinil Market Size (2014-2019)
• 11.2 Armodafinil Key Players in Central & South America
• 11.3 Central & South America Armodafinil Market Size by Type
• 11.4 Central & South America Armodafinil Market Size by Application

12 International Players Profiles

• 12.1 Teva
  • 12.1.1 Teva Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Armodafinil Introduction
  • 12.1.4 Teva Revenue in Armodafinil Business (2014-2019)
  • 12.1.5 Teva Recent Development
• 12.2 Mylan
  • 12.2.1 Mylan Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Armodafinil Introduction
  • 12.2.4 Mylan Revenue in Armodafinil Business (2014-2019)
  • 12.2.5 Mylan Recent Development
• 12.3 Apotex
  • 12.3.1 Apotex Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Armodafinil Introduction
  • 12.3.4 Apotex Revenue in Armodafinil Business (2014-2019)
  • 12.3.5 Apotex Recent Development
• 12.4 Lupin
  • 12.4.1 Lupin Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Armodafinil Introduction
  • 12.4.4 Lupin Revenue in Armodafinil Business (2014-2019)
  • 12.4.5 Lupin Recent Development
• 12.5 Sandoz
  • 12.5.1 Sandoz Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Armodafinil Introduction
  • 12.5.4 Sandoz Revenue in Armodafinil Business (2014-2019)
  • 12.5.5 Sandoz Recent Development
• 12.6 Natco Pharma
  • 12.6.1 Natco Pharma Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Armodafinil Introduction
  • 12.6.4 Natco Pharma Revenue in Armodafinil Business (2014-2019)
  • 12.6.5 Natco Pharma Recent Development
• 12.7 Aurobindo
  • 12.7.1 Aurobindo Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Armodafinil Introduction
  • 12.7.4 Aurobindo Revenue in Armodafinil Business (2014-2019)
  • 12.7.5 Aurobindo Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil.
In 2018, the global Armodafinil market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Armodafinil status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Armodafinil development in United States, Europe and China.

The key players covered in this study
Teva
Mylan
Apotex
Lupin
Sandoz
Natco Pharma
Aurobindo
...

Market segment by Type, the product can be split into
50 mg Tablets
150 mg Tablets
200 mg Tablets
250 mg Tablets

Market segment by Application, split into
Obstructive Sleep Apnea (OSA) and Narcolepsy
Shift Work Disorder (SWD)
Patients with Severe Hepatic Impairment
Geriatric Patients

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Armodafinil status, future forecast, growth opportunity, key market and key players.
To present the Armodafinil development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Armodafinil are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.